Clinical trial
Capecitabine Combined With Cisplatin in Treating Patients With Locally Advanced…
NCT00010023 · NYU Langone Health, Other · Completed
Key facts
| NCT number | NCT00010023 |
|---|---|
| Title | Capecitabine Combined With Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors |
| Official title | A Phase I Study of Oral Fluoropyrimidine Capecitabine (Xeloda Roche) Combined With Intravenous Cisplatin in Patients With Advanced Cancer of the Digestive System |
| Lead sponsor | NYU Langone Health, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Cancer |
| Intervention type | Drug |
| Interventions | capecitabine, cisplatin |
| Start date | Aug 1, 2000 |
| Primary completion | Aug 1, 2007 |
| First posted | Jan 27, 2003 |
| Last update posted | Apr 5, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: